{
    "summary": "This bill, H.R. 1492, seeks to amend title XI of the Social Security Act. It aims to equalize the drug price negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. Specifically, it proposes to extend the negotiation period for small-molecule drugs from 7 years to 11 years, aligning it with the period for biologic drugs.",
    "tags": [
        "Healthcare",
        "Social security",
        "Consumer protection",
        "Elderly care",
        "Healthcare access"
    ],
    "category": "Healthcare & Public Health"
}